“Those who are old enough may remember ‘the boy in the bubble,’ David Vetter, born with a rare hereditary condition called severe combined immunodeficiency (SCID). It affected his immune system, making even the mildest of infections life-threatening. Vetter died in 1984, at age 12.

In a new study, researchers from UCLA, University College London, and Great Ormond Street Hospital, London, trialed an experimental gene therapy for children born with severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID), demonstrating a 95% long-term success rate.”

From New Atlas.